Vaccination News Home Page

http://www.cnn.com/2003/HEALTH/parenting/01/04/prozac.kids.ap/index.html

FDA approves Prozac for children

Monday, January 6, 2003 Posted: 4:46 PM EST (2146 GMT)


Story Tools
Save a link to this article and return to it at www.savethis.comSave a link to this article and return to it at www.savethis.com  Email a link to this articleEmail a link to this article   Printer-friendly version of this articlePrinter-friendly version of this article  View a list of the most popular articles on our siteView a list of the most popular articles on our site  

WASHINGTON (AP) -- Prozac is now formally available for depressed children.

Psychiatrists have prescribed the world's best-known antidepressant, and similar competitors, to their youngest patients for years, despite a shortage of studies proving they work in children.

But the Food and Drug Administration declared Friday that there's finally proof that Prozac alleviates depression in children 8 years and older, the first drug among the newer antidepressants, which boost the mood regulator serotonin, to win such approval.

Maker Eli Lilly & Co. said it didn't intend to market Prozac for children. Still, putting child-specific information on Prozac's FDA-mandated label means more doctors, not just depression specialists, may prescribe it.

The FDA also approved Prozac's use in children with obsessive-compulsive disorder, the third serotonin-enhancing drug to win that designation.

Prozac side effects are similar for adults and children, including nausea, tiredness, nervousness, dizziness and difficulty concentrating, the FDA said.

But children have one unique side effect: In one study, children and teenagers taking Prozac grew a little more slowly -- a half inch less in height and 2 pounds less in weight over a period of 19 weeks -- than similarly aged children taking a dummy pill.

No one yet knows if the Prozac patients catch up or how big a concern that is, said the FDA's Dr. Russell Katz. Lilly agreed to further study the side effect.

Up to 2.5 percent of U.S. children and 8 percent of teenagers suffer depression, the FDA said. Additionally, about 2 percent of the population has obsessive-compulsive disorder, and at least a third of those cases began in childhood.

Psychiatrists welcomed the FDA's move.

"It made sense to prescribe these drugs, but yet everyone who did it felt a certain amount of anxiety that we didn't have all the data," said Dr. Lois Flaherty of the American Psychiatric Association.

Manufacturers have little incentive to study adult drugs in children if they expect desperate pediatricians will use the medicines anyway. In 1998, the FDA tried to require more pediatric testing, but a federal court recently threw out that requirement.


 


Copyright 2003 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.